HPV Vaccination, Infection Rates Examined in US Women
Reduction in HPV-16/18 infection prevalence seen among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women.
HPV Information Center
Teens Love Text Messages: Text Message Reminder Systems Improve HPV Vaccination Rates
Researchers examine the effectiveness of text message reminder systems on HPV vaccination rates among teens.
Effect of a National HPV Immunization Program on Cervical Cancer Incidence
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
Human Papillomavirus Infection Tied to Preterm Birth Risk
Risk increased for both persistent and placental infection and for both spontaneous and all preterm births.
2015 to 2018 Saw Decrease in HPV Infections Among Young Women
There have been significant declines in vaccine-type HPV infections among both vaccinated and unvaccinated adolescent girls and young adult women.
Updates to the 2021 Adult Immunization Schedule
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
Parental HPV Vaccine Hesitancy Increased During 2012 to 2018
From 2012 to 2018, there was an increase in the proportion of unvaccinated adolescents who were recommended the HPV vaccine by their provider.
Incidence and Clearance of High-Risk HPV in Gay and Bisexual Men
Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.
HPV Vaccine Generally Well Tolerated in Men
Human papillomavirus (HPV) vaccines are safe and well tolerated in male patients, with few reports of adverse events.
Interventions to Increase HPV Vaccine Coverage Cost-Effective
Three interventions for increased human papillomavirus vaccine coverage are cost-effective.
HPV Prevalence Higher in Adults With More Than 5 Lifetime Sexual Partners
Clinicians must consider patient sexual history in the decision-making process for adult HPV vaccination.
Artificial Intelligence Provides Benefit for Cervical Cancer Screening
For women undergoing HPV-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained slides reduces the number of colposcopies compared with current standards.
Gardasil 9 Approved to Prevent Certain HPV-Related Head and Neck Cancers
The FDA has approved an expanded indication for Gardasil 9® (human papillomavirus 9-valent vaccine [HPV], recombinant; Merck) to include the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58 in patients aged 9 to 45 years.
HPV Vaccine Toolkit Increases Vaccination Rates in Primary Care
The purpose of this project is to implement and evaluate the effectiveness of the 4 Pillars Practice Transformation Program to increase uptake of the HPV vaccine among pediatric patients.
Bivalent HPV Vaccine Induces Robust Serologic Response Nine Years Postvaccination
In addition to high antibody levels, factors including exposure to the human papillomavirus (HPV) and antibody avidity may be important and necessary to protect against infection.
Human Papillomavirus Vaccination: Review of Expanded Indications
Despite reassuring safety data from clinical trials, the adoption of the inactivated HPV vaccine in the United States remains low.
How Does the New 2-Dose HPV Vaccine Improve Delivery in Primary Care?
Survey results reveal HPV vaccine delivery practices and experiences among pediatricians and family physicians.
Studies Confirm Safety of 9-Valent HPV Vaccination
Studies based on searching Vaccine Adverse Event Reporting System, 6 Vaccine Safety Datalink sites.
HPV DNA Identified in Oral Cavity of 6.2% of Teen Girls
Human papillomavirus DNA is detected in the oral cavities of about 6.2% of sexually active female adolescents,
2018 Vaccination Coverage Rates Among Adolescents in the United States
In 2018, adolescent vaccination coverage in the United States continued to improve for meningococcal and HPV vaccines and remains high for tetanus and reduced diphtheria toxoids and acellular pertussis vaccine.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in HPV Information Center
Loading... 
Loading...